2008
DOI: 10.1016/j.jdermsci.2008.02.007
|View full text |Cite
|
Sign up to set email alerts
|

On the effects of topical synthetic pseudoceramides: Comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramides

Abstract: Taken together with preclinical safety studies of these pseudo-Cer and their widespread use over the counter without evidence of toxicity, these studies provide further assurance about the safety of these pseudo-Cer for topical use.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
17
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 23 publications
(19 citation statements)
references
References 40 publications
2
17
0
Order By: Relevance
“…This is in line with previous in vitro studies showing decreased viability of basal keratinocytes with ceramide doses above 10 lM (18,27). Further contribution of PS, C6-PS or ceramide III to induction of UVB-induced apoptosis which per se is partially caused by endogenous ceramide generation (19,28) could not be verified at the level of caspase-3 activity and nucleosomal fragmentation.…”
Section: Resultssupporting
confidence: 88%
“…This is in line with previous in vitro studies showing decreased viability of basal keratinocytes with ceramide doses above 10 lM (18,27). Further contribution of PS, C6-PS or ceramide III to induction of UVB-induced apoptosis which per se is partially caused by endogenous ceramide generation (19,28) could not be verified at the level of caspase-3 activity and nucleosomal fragmentation.…”
Section: Resultssupporting
confidence: 88%
“…In an effort to substitute lipids, the topical application of a synthetic ceramide showed inhibition of skin inflammation in a NC/Nga mouse model of AD, 12 and a potential topical synthetic pseudoceramide lacked keratinocyte toxicity in vitro. 13 These data are concordant with a previous observation that a ceramide-dominant, physiologic lipid-based emollient was well tolerated and improved disease severity in 24 children with AD as an add-on therapy. 14 In addition, a cream containing a preparation of Streptococcus thermophilus was claimed to be effective in enhancing stratum corneum ceramide levels in healthy volunteers because of the high levels of neutral sphingomyelinase activity in this organism.…”
Section: Role Of Epidermal Barrier Dysfunction In Ad Pathogenesissupporting
confidence: 91%
“…SC CERs can be generated either by serine palmitoyl transferase catalyzed de novo synthesis, which converts palmitoyl-CoA and L -serine into CERs [35], or by β- glucocerebrosidase [36] and acid sphingomyelinase [37] catalyzed hydrolysis of glucosylceramides (GlcCERs) and sphingomyelin (SPM), respectively. Large quantities of GlcCER and SPM precursors are produced in the epidermis and delivered to SC extracellular lipid domains.…”
Section: Epidermal Cers and Glucosylceramidesmentioning
confidence: 99%
“…The CERs used in lipid-based formulations and related researches are either synthetic versions of the natural skin CER analogues [26,54,163,164] and pseudo-CERs [35], or isolated from bovine brain [37] or produced biotechnologically. Although skin-similar CERs are found in plants, little effort has been made to investigate the potential applications of topically administered phytoCER formulations for diseased, aged, and affected skin.…”
Section: Topical Delivery Of Phytocersmentioning
confidence: 99%